Peer-reviewed Artikel
Biochem Biophys Res Commun. 2017 Sep 9;491(1):40-46.
Non-canonical pathway induced by Wnt3a regulates β-catenin via Pyk2 in differentiating human neural progenitor cells.
Narendra Talabattula VA, Morgan P, Frech MJ, Uhrmacher AM, Herchenröder O, Pützer BM, Rolfs A, Luo J.Mol Cancer. 2017 Jan 26;16(1):24.
MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
Spitschak A, Meier C, Kowtharapu B, Engelmann D, Pützer BMCell Stem Cell. 2016 Jun 2;18(6):797-808.
Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis.
Song G, Pacher M, Balakrishnan A, Yuan Q, Tsay H-C, Yang D, Reetz J, Brandes S, Dai Z, Pützer BM, Araúzo-Bravo MJ, Steinemann D, Luedde T, Schwabe RF, Manns MP, Schöler HR, Schambach A, Cantz T, Ott M, Sharma AD.J Urol. 2016 Aug;196(2):570-8.
Integrated loss of miR-1/-101/-204 discriminates metastatic from non-metastatic penile carcinomas and can predict patient outcome.
Hartz JM, Engelmann D, Fürst K, Marquardt S, Spitschak A, Goody D, Protzel C, Hakenberg OW, Pützer BM.Cancer Res. 2016 Jan 15;76(2):197-205.
p73 and IGF1R regulate emergence of aggressive cancer stem-like features via miR-885-5p control.
Meier C, Hardtstock P, Joost S, Alla V, Pützer BM.J Neurooncol. 2016 Feb;126(3):585-92.
Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme.
Henker C, Kriesen T, Fürst K, Goody D, Glass Ä, Pützer BM, Piek J.Nucleic Acids Res. 2016 Jan 8;44(1):117-33.
Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures.
Wang Y, Alla V, Goody D, Gupta SK, Spitschak A, Wolkenhauer O, Pützer BM, Engelmann D.Cancer Metastasis Rev. 2013 Dec;32(3-4):511-34.
Functions, divergence and clinical value of TAp73 isoforms in cancer.
Logotheti S, Pavlopoulou A, Galtsidis S, Vojtesek B, Zoumpourlis V.Int J Cancer. 2016 Apr 1;138(7):1792-801.
Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation.
Casalegno-Garduño R, Schmitt A, Spitschak A, Greiner J, Wang L, Hilgendorf I, Hirt C, Ho AD, Freund M, Schmitt M.Nature. 2015 Aug 6;524(7563):47-53.
